East Tennesseeans have CyberKnife to treat tumors right at home in Knoxville, TN
The CyberKnife Stereotactic Radiosurgery System is cleared by the U.S. Food and Drug Administration to treat malignant and benign tumors and lesions throughout the body—such as with lung cancer and brain tumors—to include those that are difficult to reach and conditions such as vascular malformations (i.e., arteriovenous malformations) and functional disorders (i.e., trigeminal neuralgia). The following is a list of various conditions treated by CyberKnife.
- Malignant Tumors
- Benign Tumors
- Vascular Malformations
- Functional Disorders
- Extracranial Tumors and Lesions
- Base of Skull
- Brain Tumors
- Neck
- Cervical Spine
- Thoracic Spine
- Lumbar Spine
- Lungs
- Pancreas
- Liver
- Other lesions, tumors and conditions anywhere on the body when radiation treatment is indicated, including prostate.
Patient benefits include the following.
- Painless treatment
- No bolted head frame
- No recovery time
- Outpatient treatment
- Short treatment courses (one to five treatments)
- FDA approved stereotactic radiosurgery system
- Covered by Medicare and most private insurances
The CyberKnife team at UT Medical Center consists of radiation oncologists, neurosurgeons and other surgical sub specialists, physicists, radiation therapists and nurses to ensure the highest quality of care possible. The team’s patient-centered care will carefully guide you though each step of your cancer / tumor treatment.
For additional information, please contact the CyberKnife Center at 865.305.6889.
For more information, see lung, liver and prostate cancers. |
